These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27199625)

  • 21. [Risk of Acute Kidney Injury in Patients Treated with Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study].
    Ide N; Sato S; Sawaguchi K
    Yakugaku Zasshi; 2019; 139(12):1609-1614. PubMed ID: 31787651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime: A Cohort Study.
    Cook KM; Gillon J; Grisso AG; Banerjee R; Jimenez-Truque N; Phillips EJ; Van Driest SL
    J Pediatric Infect Dis Soc; 2019 Jul; 8(3):221-227. PubMed ID: 29590376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
    Rutter WC; Cox JN; Martin CA; Burgess DR; Burgess DS
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Kidney Injury in Pediatric Patients Treated with Vancomycin and Piperacillin-Tazobactam Versus Vancomycin and Cefotaxime: A Single-center Study.
    Alqurashi R; Batwa M; Alghamdi B; Aljohani S; Zaher N; Alzahrani A; Aldigs E; Safdar O
    Cureus; 2020 Jan; 12(1):e6805. PubMed ID: 32140363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury.
    Tang Girdwood S; Hasson D; Caldwell JT; Slagle C; Dong S; Fei L; Tang P; Vinks AA; Kaplan J; Goldstein SL
    J Antimicrob Chemother; 2023 Feb; 78(2):478-487. PubMed ID: 36545869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam or Cefepime in Sepsis-Associated Acute Kidney Injury.
    Whitenack K; Behal ML; Thompson Bastin ML; Aycinena JC; Adams PM; Flannery AH
    Front Nephrol; 2022; 2():. PubMed ID: 36507064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.
    Kim T; Kandiah S; Patel M; Rab S; Wong J; Xue W; Easley K; Anderson AM
    BMC Res Notes; 2015 Oct; 8():579. PubMed ID: 26476979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
    Peyko V; Smalley S; Cohen H
    J Pharm Pract; 2017 Apr; 30(2):209-213. PubMed ID: 26912532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis.
    Luther MK; Timbrook TT; Caffrey AR; Dosa D; Lodise TP; LaPlante KL
    Crit Care Med; 2018 Jan; 46(1):12-20. PubMed ID: 29088001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
    Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y
    Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis.
    Giuliano CA; Patel CR; Kale-Pradhan PB
    Pharmacotherapy; 2016 Dec; 36(12):1217-1228. PubMed ID: 27805728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
    Balcı C; Uzun Ö; Arıcı M; Hayran SA; Yüce D; Ünal S
    Int J Antimicrob Agents; 2018 Aug; 52(2):180-184. PubMed ID: 29649586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study.
    O'Callaghan K; Hay K; Lavana J; McNamara JF
    Int J Antimicrob Agents; 2020 Jul; 56(1):106010. PubMed ID: 32413387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combinatorial Vancomycin and Piperacillin/Tazobactam Results in Elevated Vancomycin Trough Concentration and Acute Kidney Injury: A Case Report].
    Sakai Y; Miwa R; Mitsuoka M; Watanabe H
    Yakugaku Zasshi; 2020; 140(5):751-754. PubMed ID: 32378679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit.
    Buckley MS; Hartsock NC; Berry AJ; Bikin DS; Richards EC; Yerondopoulos MJ; Kobic E; Wicks LM; Hammond DA
    J Crit Care; 2018 Dec; 48():32-38. PubMed ID: 30172962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Kidney Injury in Non-Intensive Care and Intensive Care Patients Treated with Vancomycin and Piperacillin-Tazobactam.
    Inage S; Nakamura S; Isoe Y; Okamoto S; Uetake S; Murakami M; Yamaguchi A; Morishima M; Nei T; Ise Y; Katayama S
    J Nippon Med Sch; 2020 May; 87(2):66-72. PubMed ID: 31611508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy.
    Workum JD; Kramers C; Kolwijck E; Schouten JA; de Wildt SN; Brüggemann RJ
    J Antimicrob Chemother; 2021 Jan; 76(1):212-219. PubMed ID: 32944771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant vancomycin and piperacillin/tazobactam treatment is associated with an increased risk of acute kidney injury in Japanese patients.
    Haruki Y; Hagiya H; Haruki M; Inoue Y; Sugiyama T
    J Infect Chemother; 2020 Oct; 26(10):1026-1032. PubMed ID: 32561128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance and microbiological efficacy of cefepime or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study.
    Triffault-Fillit C; Mabrut E; Corbin K; Braun E; Becker A; Goutelle S; Chaudier P; Fessy MH; Dupieux C; Laurent F; Gunst S; Lustig S; Chidiac C; Ferry T; Valour F
    J Antimicrob Chemother; 2020 Aug; 75(8):2299-2306. PubMed ID: 32407512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.